Compare SIGI & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SIGI | BIRK |
|---|---|---|
| Founded | 1926 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 7.0B |
| IPO Year | N/A | 2023 |
| Metric | SIGI | BIRK |
|---|---|---|
| Price | $82.17 | $38.54 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $85.80 | $61.43 |
| AVG Volume (30 Days) | 549.6K | ★ 1.9M |
| Earning Date | 04-22-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.41 | $13.71 |
| Revenue Next Year | $4.81 | $14.30 |
| P/E Ratio | ★ $11.38 | $17.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $71.75 | $33.06 |
| 52 Week High | $91.63 | $57.39 |
| Indicator | SIGI | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 50.96 |
| Support Level | $81.72 | $37.73 |
| Resistance Level | $85.84 | $42.31 |
| Average True Range (ATR) | 2.63 | 1.65 |
| MACD | 0.23 | -0.11 |
| Stochastic Oscillator | 51.03 | 34.21 |
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.